Cosmos Health Inc. (COSM) |
|
1.42 -0.15 (-9.55%)
|
10-02 16:00 |
|
Open: |
1.51 |
Pre. Close: |
1.57 |
|
High:
|
1.575 |
Low:
|
1.41 |
|
Volume:
|
516,178 |
Market Cap:
|
19(M) |
|
|
|
Technical analysis |
as of: 2023-10-02 4:49:13 PM |
|
Short-term rate:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 1.92 One year: 2.39 |
| Support: |
Support1: 0.99 Support2: 0.82 |
| Resistance: |
Resistance1: 1.64 Resistance2: 2.04 |
| Pivot: |
1.56  |
| Moving Average: |
MA(5): 1.63 MA(20): 1.45
MA(100): 2.28 MA(250): 2.71 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 49.8 %D(3): 59.6 |
| RSI: |
RSI(14): 46.4 |
| 52-week: |
High: 23.84 Low: 0.06 |
| Average Vol(K): |
3-Month: 1,714 (K) 10-Days: 1,184 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ COSM ] has closed above bottom band by 29.8%. Bollinger Bands are 10.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.58 - 1.59 |
1.59 - 1.6 |
|
Low:
|
1.38 - 1.4 |
1.4 - 1.41 |
|
Close:
|
1.4 - 1.42 |
1.42 - 1.43 |
|
Company Description |
|
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois. |
Headline News |
Thu, 28 Sep 2023
Ticking Time Bombs: 3 Healthcare Stocks to Dump Before the ... - InvestorPlace
Wed, 27 Sep 2023
Is Cosmos Health Inc (COSM) Stock a Smart Value Wednesday? - InvestorsObserver
Tue, 26 Sep 2023
Cosmos Health Announces Expansion of Its C-Sept Brand with the ... - StreetInsider.com
Thu, 21 Sep 2023
Cosmos Health Announces Strategic Collaboration with C.A. ... - Marketscreener.com
Wed, 13 Sep 2023
Cosmos Health Starts Stock Buyback Program - Yahoo Finance
Tue, 25 Jul 2023
Cosmos Health Provides Update on Recent Developments, Maintains Strong Financial Position, Reaffirms Commitment to Growth, and Highlights CEO's Continued Investment Now Exceeds $15 Million - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
13 (M) |
| Shares Float |
10 (M) |
|
% Held by Insiders
|
14.9 (%) |
|
% Held by Institutions
|
4.5 (%) |
|
Shares Short
|
409 (K) |
|
Shares Short P.Month
|
480 (K) |
Stock Financials |
|
EPS
|
-1.53 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
3.99 |
|
Profit Margin (%)
|
-29.2 |
|
Operating Margin (%)
|
-26.4 |
|
Return on Assets (ttm)
|
-13.9 |
|
Return on Equity (ttm)
|
-54.6 |
|
Qtrly Rev. Growth
|
-6.5 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
3.73 |
|
EBITDA (p.s.)
|
-0.98 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-24 (M) |
|
Levered Free Cash Flow
|
-15 (M) |
Stock Valuations |
|
PE Ratio
|
-0.93 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.35 |
|
Price to Sales
|
0.38 |
|
Price to Cash Flow
|
-0.78 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
